Term
| Coding for Diabetes mellitus without complication |
|
Definition
|
|
Term
| Coding for Diabetes mellitus with ophthalmic manifestations |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Code for type 2 or unspecified not stated as uncontrolled, patient may or may not be using insulin |
|
Definition
|
|
Term
| Code for type 1 not stated as uncontrolled |
|
Definition
|
|
Term
| Code for type 2 or unspecified , uncontrolled, patient may or may not be using insulin |
|
Definition
|
|
Term
| Code for type 1, uncontrolled |
|
Definition
|
|
Term
| Diabetic Retinopathy coding: PDR |
|
Definition
|
|
Term
| Diabetic Retinopathy coding: NPDR NOS |
|
Definition
|
|
Term
| Diabetic Retinopathy coding: Mild NPDR |
|
Definition
|
|
Term
| Diabetic Retinopathy coding: Moderate NPDR |
|
Definition
|
|
Term
| Diabetic Retinopathy coding: Severe NPDR |
|
Definition
|
|
Term
| When do you refer within 24-48 hours |
|
Definition
| High risk PDR or Vitreous heme |
|
|
Term
| 3 situations where you refer within 2-4 weeks |
|
Definition
Macular edema
Severe or very severe NPDR
Early (non-high risk) PDR |
|
|
Term
|
Definition
Thickening of retina 1/3 DD (500 microns) from macula
Hard exudates 1/3 DD from macula with adjacent retinal thickening
Thickening of the retina 1DA in size 1 DD from the macular |
|
|
Term
| Criteria of High Risk PDR |
|
Definition
NVD >1/4-1/3 DA
NVD with VH or PRH
NVE >1/2DA with VH or PRH |
|
|
Term
| Name the 9 pertinent negatives |
|
Definition
H/MA
VB
IRMA
CWS
NVI
NVD
NVE
HE
CSME |
|
|
